ArticlePatient preference and adherence2025
Treatment Goals in Schizophrenia: Subgroup Analysis of a Survey in Matched Physician-Patient Pairs.
Article in Patient preference and adherence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Treatment Goals in Schizophrenia as Seen by Matched Patients and Physicians: Preferences and Medication Formulation Strategies.Neuropsychiatric disease and treatment · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Schizophrenia is a complex disease that affects many aspects of the lives of people living with the disease. Therefore, many different treatment goals are possible. Treatment goals in schizophrenia may differ between patients and physicians. Here, we set out to explore whether there are subgroups in which differences between patient goals and treating psychiatrist's goals are especially marked, which would highlight the need for better dialogue between psychiatrists and patients belonging to these subgroups. Methods: In a survey, patients with schizophrenia and their treating psychiatrists were asked about treatment goals. To this end, questionnaires were sent to psychiatrists all over Germany. Psychiatrists were asked to rank and rate a prespecified set of treatment goals for up to 3 specific patients. Furthermore, these same patients were asked to rank and rate the goals for themselves. Responses are analyzed in subgroups of patients stratified by sex, disease duration (≤5 years/>5 years) and treatment by psychiatrists in private practice vs hospital-based psychiatrists. Results: We obtained answers from 28 physicians, 17 of which worked exclusively in private practice, and 80 patients. Of the patients, 13 had a disease duration ≤5 years, 31 were female, and 52 were treated by psychiatrists in private practice. Concordance between patients and their physicians was fairly high, and none of the subgroups (shorter/longer disease duration, male/female sex, treatment by psychiatrists in private practice vs hospital-based psychiatrists) stood out as markedly different from the total cohort. The most marked differences between patients and physicians regarded avoidance of different possible medication side effects. Conclusion: We did not find any major differences between the subgroups in this study. Overall, there was a high concordance of rankings and ratings of treatment goals. Patients tended to focus on different side effects than physicians, indicating that these should be discussed thoroughly when making a treatment decision.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.